For the Inventor, By the Inventor

Enter assignee name

Mountain View, CA, United States of America

Pneumrx, Inc.

USPTO Granted Patents = 47

% Expired Patents = 95.7

CIPO Patents = 5

EPO Patents = 10

Trademarks = 1

Forward Citations = 979

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

Mark L Mathis (35 out of 114 patents)

Patrick Peichen Wu (17 out of 49 patents)

David P Thompson (15 out of 159 patents)

4. Ronald Dieck (13 out of 27 patents)

5. David Lehrberg (13 out of 13 patents)

6. Nathan Aronson (12 out of 27 patents)

7. Glen Gong (9 out of 20 patents)

8. Jaime Vasquez (9 out of 9 patents)

9. Michael P Boutillette (5 out of 34 patents)

10. Andrew Stein (5 out of 5 patents)

11. Erin McGurk (5 out of 13 patents)

12. Timothy R Machold (3 out of 139 patents)

13. Verna Rodriguez (3 out of 3 patents)

14. Edmund J Roschak (2 out of 42 patents)

15. Kara Andersen Reiter (2 out of 2 patents)

Core Competencies:

Guidewire

Lung Volume Reduction

Chronic Obstructive Pulmonary Disease

Medical Devices

Minimally Invasive

Glue Composition

Pulmonary Artery

Target Site Access

Dissection Kits

Implant Structures

Efficacy Enhancement

47 patents: Sort by Forward Citations

1. 10555736 - Guidewire (2020-02-11),

2. 10543053 - Containers for medical devices (2020-01-28),

3. 10537334 - Genetically-associated chronic obstructive pulmonary disease treatment (2020-01-21),

4. 10390838 - Tuned strength chronic obstructive pulmonary disease treatment (2019-08-27),

5. 10285707 - Enhanced efficacy lung volume reduction devices, methods, and systems (2019-05-14),

6. 10226257 - Lung volume reduction devices, methods, and systems (2019-03-12),

7. RE47231 - Glue composition for lung volume reduction (2019-02-11),

8. 10188398 - Cross-sectional modification during deployment of an elongate lung volume reduction device (2019-01-29),

9. 10188397 - Torque alleviating intra-airway lung volume reduction compressive implant structures (2019-01-29),

10. 10166041 - Devices, systems, methods and kits for performing selective dissection of lung tissue (2019-01-01),

11. 10058331 - Enhanced efficacy lung volume reduction devices, methods, and systems (2018-08-28),

12. 10034999 - Steerable device for accessing a target site and methods (2018-07-31),

13. D818700 - Container for medical implant (2018-05-29),

14. 9839408 - Method and system for measuring pulmonary artery circulation information (2017-12-12),

15. 9801637 - Genetically-associated chronic obstructive pulmonary disease treatment (2017-10-31),

Pneumrx, Inc. is a medical device company based in Mountain View, California, specializing in innovative solutions for chronic obstructive pulmonary disease (COPD) and related pulmonary conditions. The company focuses on the development of minimally invasive devices, including steerable access devices and guidewire technologies, aimed at enhancing lung volume reduction procedures. Their expertise extends to glue compositions and selective lung tissue dissection, contributing to advancements in pulmonary artery circulation and improving patient outcomes.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

47 Patents

#72 in Mountain View, CA

#1,752 in California

#7,425 in US

#14,796 in the World

Mountain View, CA, United States of America

Pneumrx, Inc.

Forward Citations = 979

24 inventors:

Mark L Mathis (35 out of 114 patents)

Patrick Peichen Wu (17 out of 49 patents)

David P Thompson (15 out of 159 patents)

4. Ronald Dieck (13 out of 27 patents)

5. David Lehrberg (13 out of 13 patents)

Please report any incorrect information to [email protected]

Loading…